Profitelligence Profitelligence · Filing Ledger Open WST research →

Form 8-K · Current Report · Filed 2025-04-14

Cindy Reiss-Clark Departs as Senior Vice President and Chief Commercial Officer at West Pharmaceutical Services

On March 7, 2025, Cindy Reiss-Clark, former Senior Vice President and Chief Commercial Officer of West Pharmaceutical Services, Inc., departed the company.

Filer
West Pharmaceutical Services Inc. WST · NYSE
Filed
Accession
0000105770-25-000022
CIK
0000105770
Signal
High impactHealthcare

Details

As part of her departure, she is entitled to severance benefits including one-year of salary continuation, continuation of welfare benefits, a 2025 payment of her pro-rated Annual Incentive Plan target, and outplacement services. These benefits are contingent upon her execution of a Separation Agreement and Release. The agreement includes a release of claims, noncompetition and nonsolicitation covenants, and a nondisparagement provision. A copy of the agreement is furnished as an exhibit to this Form 8-K.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

Key Executive Departure
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$210.70

Next session

+0.9%

Since filing

+61.8%

Latest close

$340.96

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from WST reporting the same item, with the next session's move:

Exhibits (1)

About West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.

Exchange NYSE Industry Medical Instruments & Supplies Company website ↗

Never miss another WST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts